MYC and breast carcinoma: Besides 4T1.2 mammary tumor cells, the anti-tumor Oct4 CM, c-Myc CM, and Oct4/c-Myc CM were also derived from MDA-MB-231 breast cancer cells as well as EO771 mammary tumor cells (Figure 4A-B, Figure S4A-B).